Annual Congress Munich 2006

---

---

PG1 - Respiratory infections: pneumonia/antibiotic resistance and clinical outcome of lower respiratory tract infections

Postgraduate Course
Chairs: F. Blasi (Milan, Italy), R. Finch (Nottingham, United Kingdom)
Aims: The main target of this course is to update the participants on current advances in knowledge regarding the management of both community- and hospital-acquired pneumonia (CAP and HAP). At the end of this course participants will be able to:
• understand the correct methodological approach to the diagnosis of pneumonia;
• define the role of the noninvasive and invasive techniques for microbiological diagnosis;
• understand the advantages and the limits of prophylactic strategies;
• understand the value and the limits of current therapeutic indications. Target audience: Clinicians, microbiologists and public health specialists involved in lower respiratory tract infection (LRTI) surveillance and control; research fellows and training specialists interested in updating their knowledge regarding the management of pneumonia.

Epidemiology of community-acquired pneumonia and nosocomial pneumonia R. Pistelli (Rome, Italy)
Aetiology of CAP and HAP: role of microbiology H. Goossens (Edegem, Belgium)
CAP and HAP guidelines: treatment indications and more M. Woodhead (Manchester, United Kingdom)
Vaccination and other preventive measures for CAP and HAP A. Ortqvist (Stockholm, Sweden)
Community and healthcare-related resistance R. Finch (Nottingham, United Kingdom)
Streptococcus pneumoniae resistance pattern and its clinical implications J. Garau Alemeny (Barcelona, Spain)
Antibiotic resistance and clinical outcomes: the CAPNETZ experience T. Welte (Hannover, Germany)
Antibiotic use and misuse in the community: how to manage the problem T. Verheij (Utrecht, Netherlands)